The identification of lymphocyte subsets with non-overlapping 22 effector functions has been pivotal to the development of targeted 23 therapies in immune mediated inflammatory diseases (IMIDs). 24 However it remains unclear whether fibroblast subclasses with non-25 overlapping functions also exist and are responsible for the wide 26 variety of tissue driven processes observed in IMIDs such as 27 inflammation and damage . Here we identify and describe the biology 28 of distinct subsets of fibroblasts responsible for mediating either 29 inflammation or tissue damage in arthritis. We show that deletion of 30 FAPα+ synovial cells suppressed both inflammation and bone 31 erosions in murine models of resolving and persistent arthritis. Single 32 cell transcriptional analysis identified two distinct fibroblast subsets: 33 FAPα+ THY1+ immune effector fibroblasts located in the synovial sub-34 lining, and FAPα+ THY1-destructive fibroblasts restricted to the 35 synovial lining. When adoptively transferred into the joint, FAPα+ 36 THY1-fibroblasts selectively mediate bone and cartilage damage with 37 little effect on inflammation whereas transfer of FAPα+ THY1+ 38 fibroblasts resulted in a more severe and persistent inflammatory 39 arthritis, with minimal effect on bone and cartilage. Our findings 40 describing anatomically discrete, functionally distinct fibroblast 41 subsets with non-overlapping functions have important implications 42 Croft et al Page 3 of 35 for cell based therapies aimed at modulating inflammation and tissue 43 damage. 44 45
success of biologic therapies in immune mediated inflammatory diseases 48 (IMIDs) and cancer 1, 2 . However, significant numbers of patients continue to 49 have refractory disease or fail to achieve complete remission 3 . These 50 observations suggest the existence of additional pathogenic pathways, 51 responsible for disease persistence, that have yet to be targeted 52
therapeutically. 53
Non-hematopoietic, tissue resident stromal cells, contribute to the 54 pathogenesis of many diseases and are known to develop epigenetically 55 imprinted, site and disease specific phenotypes 4-7 . Rheumatoid arthritis 56 (RA) is a prototypic IMID 8 in which synovial fibroblasts (SFs) play a key role 57 in the destruction of articular cartilage and bone 9,10 but also modulate the 58 joint microenvironment to favour the persistence of inflammation 11 . 59
However, it remains unknown whether the processes of inflammation and 60 tissue damage are mediated by different subsets of fibroblasts or, instead, 61 reflect cellular plasticity residing within a single fibroblast population 7, 13 . 62
While recent studies have furthered our understanding of the transcriptional 63 heterogeneity of human SFs during inflammation 12,13 , the functional 64 significance of the fibroblast subsets identified in such studies is unknown. A clearer understanding of the biology of SFs is therefore essential to 66 provide a coherent rationale for their therapeutic targeting 67
We found that expression of fibroblast activation protein α (FAPα), a cell 68 membrane dipeptidyl peptidase 14 , was significantly higher in synovial tissue 69 of patients who fulfilled diagnostic criteria for RA over time, compared to 70 patients in whom joint inflammation eventually resolved (Fig 1A,B) . 71
Furthermore, expression of the Fap gene in cultured SFs isolated from 72 patients with early RA was increased in vitro (Fig 1C) compared to other 73 diagnostic groups. This suggests that the FAPα+ associated cell phenotype 74 may be pathogenic. 75
To map the expression of FAPα in RA synovium we used mass cytometry 76 (CyTOF) analysis of the stromal compartment of the synovial membrane 77 using a combination of podoplanin (PDPN), to identify fibroblasts and 78 THY1 (CD90) to identify sub-lining layer (SL) from lining layer (LL) 79 fibroblasts as validated in previous studies 12, 13, 15 . FAPα expression co-80 localized with PDPN in both the LL and SL cells (Fig 1D) . A small subset of 81 pericytes (defined as CD45-, PDPN-and THY1+) also expressed FAPα. 82
These findings were confirmed by confocal analysis of RA synovium (Fig  83   1E) . 84
To determine the role of FAPα+ SFs in inflammation, we induced serum 85 transfer inflammatory arthritis (STIA) in a transgenic FAPα luciferase-DTR 86 reporter mouse 16 . FAPα expression increased during the course of arthritis 87 (Fig 1F,G) . The level of bioluminescence correlated with the severity of 88
Croft et al Page 5 of 35 joint swelling (Fig 1H) . Synovial expression of FAPα was either low or 89 undetectable under resting conditions (extended data 1A) by histology, but 90 increased throughout the synovial membrane (SM) and focal areas of 91 pannus tissue invading cartilage and bone during inflammation (Fig 1I,J,  92 extended data 1A). 93
During arthritis, FAPα expression was restricted to stromal cells (extended 94 data 1B,C,D) and the number of FAPα expressing fibroblasts increased 95 during inflammation returning to baseline levels following resolution ( Fig  96   1K and extended data 1C,E), confirming that FAPα is an accurate marker 97 of tissue inflammation (Fig 1F-K 
, extended data 1A,C,E). 98
In the murine synovium, THY1 expression also distinguished the SL from 99 LL fibroblasts, with PDPN and FAPα expressed in both cellular 100 compartments (Fig 1L, M) . To determine how FAPα expressing cell 101 populations changed during arthritis, we quantified their absolute number 102 and assessed their proliferative capacity, by both BrdU incorporation and 103
Ki67 staining using flow cytometry (Fig 1N) . The severity of joint 104 inflammation positively correlated with an increase in the total number of 105 FAPα+ THY1+ expressing cells but not FAPα+THY1-cells. (extended data 106
1F-H). A significant increase in the proliferation of both THY1-FAPα+ (LL) 107
and THY1+ FAPα+ (SL) cells was observed during inflammation, with 108 THY1+ FAPα+ cells expanding the most (Fig 1N) . In contrast, there was 109 very little change in the number of FAPα expressing pericytes (Fig 1N) . inflamed SM compared to resting state (Fig 1O) and positively correlated 112 with the severity of ankle swelling (Fig 1P) . Collectively these data support 113 the idea that expansion of a potentially pathogenic population of SFs 114 marked by a PDPN, FAPα and THY1 expression, occurs in the inflamed 115
synovium. 116
To determine if FAPα+ fibroblasts play a direct functional role in arthritis we 117 selectively deleted FAPα expressing cells at various stages of arthritis 118 The reduction in arthritis following FAPα+ cell deletion was observed in 132 both resolving and persistent models of arthritis (Fig 2B) . cluster marker genes revealed a diversification of function between the 172 subsets: F1 fibroblast marker genes were over-represented in "extracellular 173 matrix organisation and repair", while F2 and F3 fibroblasts showed an 174 enrichment for the "immune", "inflammatory response" and "complement 175 activation" biological processes. F4 fibroblasts express genes characteristic 176 of an actively cell cycling population while F5 fibroblasts were over-177
represented in gene expression associated with "transmembrane 178 transporter activity" (Fig 3C) . Examination of the top cluster marker genes 179 allowed us to easily differentiate these five subsets at the mRNA expression 180
Croft et al Page 9 of 35 level (Fig 3D) . While Pdpn and Fap were expressed by all of the fibroblast 181 subsets, Thy1 was expressed selectively by F1-F4 fibroblasts but not F5 182 fibroblasts ( Fig 3D, extended data 7) , suggesting that we could use THY1 183 as a marker to discriminate the lining layer F5 subset from the four sub-184 lining subsets (F1-F4). We also examined the expression of other known 185 fibroblast markers across the subsets as well as the specific expression of 186 selected chemokines (extended data 8A,C). 187
To confirm the validity of using PDPN, THY1 and FAPα as a cassette of cell 188 surface markers able to discriminate LL and SL, we performed ultra-low purified stimulated FAPα expressing THY1+ and THY1-cells (Fig 4A) . 213
Moreover, FAPα+ THY1-cells expressed RANKL on their cell surface, 214 secreted higher levels of RANKL and exhibit a significantly increased 215 RANKL/OPG ration compared to FAPα+ THY1+ (Fig 4B,C) . Taken together 216 these results strongly suggested that the THY1-and THY1+ cells might 217 perform distinct non-overlapping functions in vivo. 218
219
To directly test this hypothesis we adoptively transferred PDPN+ FAPα+ 220 THY1-or PDPN+ FAPα+ THY1+ cells directly into the inflamed ankle joint 221 of mice. Injection of PDPN+ FAPα+ THY1+ cells resulted in more severe 222 and sustained paw swelling (Fig 4D) , with higher levels of leucocyte 223 infiltration compared to sham injected joints (Fig 4E) but with little effect on 224 bone and cartilage destruction (Fig 4F,G) . In contrast, the injection of PDPN+ FAPα+ THY1-cells had no effect on the severity or temporal 226 dynamics of joint inflammation ( Fig 4D) , but did result in increased 227 osteoclast activity, increased bone erosion and structural joint damage (Fig  228   4F,G) . Collectively, these data suggest that in pathological conditions 229 PDPN+ FAPα+ THY1+ expressing cells assume an immune effector role 230 capable of sustaining inflammation through the production of a distinct 231 repertoire of chemokines and cytokines, whereas PDPN+ FAPα+ THY1-232 cells are bone effector cells that mediate joint damage. 233
In support of this conclusion, and as validation of the relevance of our 234 findings to human disease, we identified an expanded population of PDPN+ 235 FAPα+ THY1+ immune effector fibroblasts in the synovia of patients with 236 RA, in whom joints are persistently inflamed, compared to patients with 237 osteoarthritis (OA), a disease characterised predominately by joint damage 238 rather than inflammation (Fig 4H) . The expansion of THY1+ FAPα+ cells 239 positively correlated with markers of systemic inflammation including 240 circulating Erythrocyte Sedimentation Rate (ESR) and the tissue Krenn 241 score, a histological measurement of synovial inflammation 17 (Fig 4I) . 242
In conclusion we have identified and described the pathological significance 243 of fibroblast heterogeneity in RA, an IMID in which inflammation and 244 damage play key pathogenic roles. We describe discrete, anatomically In addition, clinical score was assessed daily as a sum of the clinical score 401 for each paw (0 -no arthritis; 1 -mild arthritis, foot maintains V-shape; 2 -402 moderate arthritis, foot no longer maintains V-shape; 3 -severe arthritis). 403
Each experiment was performed 2-5 times to confirm reproducibility. common to more than one sample were removed from the aggregated 465 count matrix. The UMI count matrix was also randomly down-sampled to 466 ensure normalization of the median number of per-cell counts between the 467 samples. Downstream analysis was performed using the Seurat R package 468 (version 2.3.0) 22 Butler:2018ex} as follows. Cells with greater than 5% 469 mitochondrial reads or fewer than 500 genes were excluded from the 470 analysis. Cells were down-sampled to a common number: for the full 471 analysis we retained n=938 cells per replicate, while n=575 cells were 472 retained per replicate for re-analysis of the fibroblasts. Per-cell counts were 473 normalised, scaled and the effects of total UMI counts and percentage of 474 mitochondrial counts regressed out. For the fibroblast re-analysis, the 475 difference between G2M and S phase was also regressed out based on the 476 expression of known cell cycle marker genes 23 . In both cases, we retained
RNA-seq gene expression quantification 502
The reads were mapped to the GRCm38 (Ensemble release 85) mouse 503 genome using STAR alignment software version v2.5.2b 25 . Read counts per 504 gene were produced by the same software. Sample normalization and 505 differential expression analysis was performed using DESeq2 R 506
Bioconductor package 26 . log2 values of read counts regularised by DESeq2 507 were used in heatmaps in extended data 11 and 12. 508 509
Luminex analysis 510
Sort purified PDPN+ FAPα+ THY1-or PDPN+ FAPα+ THY1+ cells were 511 stimulated with 1ng/ml recombinant mouse IL-1β (Peprotech) ex-vivo in 512 culture medium for 1 hour. Fresh culture media was then applied and the 513 subsequent supernatant was harvested after 12 hours and analysed using 514 custom selected multiplex bead based assays (Luminex assay panel, R&D 515 systems). 516 517
Blood biochemistry 518
Murine blood was collected under terminal anaesthesia by cardiac puncture 519 into heparinized tubes. Plasma was collected and analysed using the APX 520 
